Stereoselective first-pass metabolism of verapamil in the small intestine and liver in rats

Drug Metabolism and Disposition

Volumn 36, Issue 10, 2008, Pages 2037-2042

  Hanada, Kazuhiko ^a   Ikemi, Yasutaka ^a   Kukita, Kazutaka ^a   Mihara, Kiyoshi ^a   Ogata, Hiroyasu ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NORVERAPAMIL; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG PROTEIN BINDING; ENANTIOMER; FIRST PASS EFFECT; LIVER; MALE; MICROSOME; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE; STEREOCHEMISTRY;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; INTESTINE, SMALL; LIVER; MALE; MICROSOMES; RATS; RATS, WISTAR; STEREOISOMERISM; VERAPAMIL;

RATTUS;

EID: 52949140154     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.020339     Document Type: Article

References (19)

1. Bhatti MM and Foster RT (1997) Pharmacokinetics of the enantiomers of verapamil after intravenous and oral administration of racemic verapamil in a rat model. Biopharm Drug Dispos 18:387-396.
2. Davies B and Morris T (1993) Physiological parameters in laboratory animals and humans. Pharm Res 10:1093-1095.
3. Echizen H, Brecht T, Niedergesass S, Vogelgesang B, and Eichelbaum M (1985a) The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans. Am Heart J 109:210-217.
4. Echizen H, Manz M, and Eichelbaum M (1988) Electrophysiologic effects of dextro- and levo-verapamil on sinus node and AV node function in humans. J Cardiovasc Pharmacol 12:543-546.
5. Echizen H, Vogelgesang B, and Eichelbaum M (1985b) Effects of d, l-verapamil on atrioven-tricular conduction in relation to its stereoselective first-pass metabolism. Clin Pharmacol Ther 38:71-76.
6. Eichelbaum M, Ende M, Remberg G, Schomerus M, and Dengler HJ (1979) The metabolism of DL-[14C]verapamil in man. Drug Metab Dispos 7:145-148.
7. Gross AS, Heuer B, and Eichelbaum M (1988) Stereoselective protein binding of verapamil enantiomers. Biochem Pharmacol 37:4623-4627.
8. Hanada K, Akimoto S, Mitsui K, Hashiguchi M, and Ogata H (1998a) Quantitative determination of disopyramide, verapamil and flecainide enantiomers in rat plasma and tissues by high-performance liquid chromatography. J Chromatogr B 710:129-135.
9. Hanada K, Akimoto S, Mitsui K, Mihara K, and Ogata H (1998b) Enantioselective tissue distribution of the basic drugs disopyramide, flecainide and verapamil in rats: role of plasma protein and tissue phosphatidylserine binding. Pharm Res 15:1250-1256.
10. Hanada K, Ohta T, Hirai M, Arai M, and Ogata H (2000) Enantioselective binding of propran-olol, disopyramide, and verapamil to human alpha(1)-acid glycoprotein. J Pharm Sci 89:751-757.
11. Hashiguchi M, Ogata H, Maeda A, Hirashima Y, Ishii S, Mori Y, Amamoto T, Handa T, Otsuka N, Irie S, et al. (1996) No effect of high-protein food on the stereoselective bioavailability and pharmacokinetics of verapamil. J Clin Pharmacol 36:1022-1028.
12. Mihara K, Matsumura M, Yoshioka E, Hanada K, Nakasa H, Ohmori S, Kitada M, and Ogata H (2001) Intestinal first-pass metabolism of eperisone in the rat. Pharm Res 18:1131-1137.
13. Nelson WL and Olsen LD (1988) Regiochemistry and enantioselectivity in the oxidative N-dealkylation of verapamil. Drug Metab Dispos 16:834-841.
14. Nelson WL, Olsen LD, Beitner DB, and Pallow RJ Jr (1988) Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver. Drug Metab Dispos 16:184-188.
15. Robinson MA and Mehvar R (1996) Enantioselective distribution of verapamil and norverapamil into human and rat erythrocytes: the role of plasma protein binding. Biopharm Drug Dispos 17:577-587.
16. Sandström R, Karlsson A, and Lennernäs H (1998) The absence of stereoselective P-glycoprotein-mediated transport of R/S-verapamil across the rat jejunum. J Pharm Pharmacol 50:729-735.
17. Sandström R, Knutson TW, Knutson L, Jansson B, and Lennernäs H (1999) The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans. Br J Clin Pharmacol 48:180-189.
18. Vogelgesang B, Echizen H, Schmidt E, and Eichelbaum M (1984) Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique. Br J Clin Pharmacol 18:733-740.
19. von Richter O, Greiner B, Fromm MF, Fraser R, Omari T, Barclay ML, Dent J, Somogyi AA, and Eichelbaum M (2001) Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique. Clin Pharmacol Ther 70:217-227.